Effect of beta blockade with and without sympathomimetic activity (ISA) on sympathovagal balance and baroreflex sensitivity

Clinical Physiology

Volumn 19, Issue 2, 1999, Pages 143-152

  Haberthur Ch ^a   Schachinger H ^a   Langewitz, W ^a   Ritz, R ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Autonomic balance; Blood pressure variability; Heart rate variability; Parasympathetic; Sympathetic; Vagal

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PINDOLOL; PROPRANOLOL;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; INTRINSIC SYMPATHOMIMETIC ACTIVITY; MALE; NORMAL HUMAN; PARASYMPATHETIC NERVE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLOW RELEASE FORMULATION; STATISTICAL ANALYSIS; SUPINE POSITION; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; TILTING; VAGUS NERVE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; BAROREFLEX; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; PINDOLOL; PROPRANOLOL; SUPINE POSITION; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS; VAGUS NERVE;

EID: 0032984406     PISSN: 01445979     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2281.1999.00162.x     Document Type: Article

References (58)

1. AHLMARK G., SAETRE H. & KORSGREN M. (1974) Reduction of sudden deaths after myocardial infarction. Lancet, 2, 1563.
2. AHMED M. W., KADISH A. H., PARKER M. A. & GOLDBERGER J. J. (1994) Effect of physiologic and pharmacologic adrenergic stimulation on heart rate variability. J Am Coll Cardiol, 24, 1082-1090.
3. ANDERSEN M. P., BECHSGAARD P., FREDERIKSEN J., HANSEN D. A., JURGENSEN H. J., NIELSEN B., PEDERSEN F., PEDERSEN-BJERGAARD O. & RASMUSSEN S. L. (1979) Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction: preliminary results. Lancet, 2, 865-868.
4. ANGELONE A. & COULTER N. A. (1964) Respiratory sinus arrhythmia in humans: a frequency dependent phenomenon. J Appl Physiol, 41, 479-482.
5. AUSTRALIAN AND SWEDISH PINDOLOL STUDY GROUP. (1983) The effect of pindolol on the two years mortality after complicated myocardial infarction. Eur Heart J, 4, 367-375.
6. BIGGER J. T. JR, ALBRECHT P., STEINMAN R. C., ROLNITZKY L. M., FLEISS J. L. & COHEN R. J. (1989a) Comparison of time- and frequency domain-based measures of cardiac parasympathetic activity in Holter recordings after myocardial infarction, Am J Cardiol, 64, 536-538.
7. BIGGER J. T. JR, LA ROVERE M. T., STEINMANN R. C., ROLNITZKY L. M., FLEISS J. L. & COHEN R. J. (1989b) Comparison of BRS and heart rate period variability after myocardial infarction. J Am Coll Cardiol, 14, 1511-1518.
8. BIGGER J. T. JR, FLEISS J. L., ROLNITZKY R. C., STEINMAN R. C. & SCHNEIDER W. J. (1991) Time course ofrecovery of heart period variability after myocardial infarction. J Am Coll Cardiol, 18, 1643-1649.
9. BIGGER J. T. JR, FLEISS J. L., STEINMAN R. C., ROLNITZKY L. M., KLEIGER R. E. & ROTTMAN J. N. (1992) Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation, 85, 164-171.
10. CONWAY J. & BILSKI A, (1980) β-blockers. In: Adrenergic Activators and Inhibitors (ed. Szekeres L.), part 3, pp. 65-104. Springer-Verlag, Berlin.
11. COOK J. R., BIGGER J. T. JR, KLEIGER R. E., FLEISS J. L., STEINMAN R. C. & ROLNITZKY L. M. (1991) Effect of atenolol and diltiazem on heart period variability in normal persons, J Am Coll Cardiol, 17, 480-484.
12. CORONARY PREVENTION RESEARCH GROUP. (1981) An early intervention secondary prevention study with oxprenolol following myocardial infarction. Eur Heart J, 2, 389-393.
13. ECKBERG D. L. (1980) Nonlinearities of the human carotid baroreceptor-cardiac reflex. Circ Res, 47, 208-216.
14. ECKBERG D. L., ABBOUD F. M. & MARK A. L. (1976) Modulation of carotid baroreflex responsiveness in man: effects of posture and propranolol. J Appl Physiol, 413, 383-387.
15. EUROPEAN INFARCTION STUDY GROUP. (1984) A secondary prevention study with slow-release oxprenolol after myocardial infarction: morbidity and mortality. Eur Heart J, 5, 189-202.
16. GRASSO R., SCHENMA F., GULLI G. & CEVESA A. (1997) Does low-frequency variability of heart period reflect a specific parasympathetic mechanism? J Auton Nerv Syst, 63, 30-38.
17. HARTIKAINEN J., MANTYSAARI M., MUSSALO H., TAHVANAINEN K., LANSIMIES E. & PYORALA K. (1995) Good exercise capacity at hospital discharge predicts recovery of baroreflex sensitivity after myocardial infarction. Eur Heart J, 16, 1520-1525.
18. HOHNLOSER S. H., KLINGENHEBEN T., VAN DE LOO A., HABLAWETZ E., JUST H. & SCHWARTZ P. J. (1994) Reflex versus tonic vagal activity as a prognostic parameter in patients with sustained ventricular tachycardia or ventricular fibrillation. Circulation, 89, 1068-1073.
19. HULL S. S. JR, VANOLI E., ADAMSON P. B., DE FERRARI G. M., FOREMAN R. D. & SCHWARTZ P. J. (1995) Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation, 91, 2516-2519.
20. JAMES M. A., PANERAI R. B. & POTTER J. F. (1998) Applicability of new techniques in the assessment of arterial baroreflex sensitivity in the elderly: a comparison with established pharmacological methods. Clin Sci, 94, 245-253.
21. JURGENSEN H. J., FREDERIKSEN J., HANSEN D. A. & PEDERSEN-BJERGAARD O. (1981) Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol. Br Heart J, 45, 583-588.
22. KAMATH M. V. & FALLEN E. L. (1991) Diurnal variations of neurocardiac rhythms in acute myocardial infarction. Am J Cardiol, 68, 155-160.
23. KAMATH M. V., UPTON A. R. M., TALLALA A. & FALLEN E. L. (1992) Effect of vagal nerve electrostimulation on the power spectrum of heart rate variability in man. Pacing and Clinical Electrophysiology, 15, 235-243.
24. KLEIGER R. E., MILLER J. P., BIGGER J. T. JR, Moss A. J. & THE MULTICENTER POST-INFARCTION RESEARCH GROUP. (1987) Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol, 59, 256-262.
25. LA ROVERE M. T., SPECCHIA G., MORTARA. A. & SCHWARTZ P. J. (1988) Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. Circulation, 78, 816-824.
26. LA ROVERE M. T., MORTARA A., CAPOMOLLA S., COBELLI F. & SCHWARTZ P. J. (1990) Autonomic reflexes and beta-blockade in post-MI patients. Eur Heart J, 11 (Suppl.), 267.
27. LA ROVERE M. T., MORTARA A., BIGGER T. J. JR, MARCUS F. I., CAMM J. A., HOHNLOSER S. H. & SCHWARTZ P. J. (1996) The prognostic value of baroreflex sensitivity and heart rate variability after myocardial infarction: the ATRAMI study. Circulation, 94 (Suppl.), 1-19.
28. LA ROVERE M. T., BIGGER J. T. JR, MARCUS F. I., MORTARA A. & SCHWARTZ P. J. (1998) Baroreflex sensitivity and heart-race variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes after Myocardial Infarction) Investigators. Lancet, 351, 478-484.
29. MAESTRI R., PINNA G. D., MORTARA A., LA ROVERE M. T. & TAVAZZI L. (1998) Assessing baroreflex sensitivity in post-myocardial infarction patients: comparison of spectral and phenylephrine techniques. J Am Coll Cardiol, 31, 344-351.
30. MAYER S. (1876) Studien zur Physiologie des Herzens und der Blutgefässe: 5. Abhandlung: Über spontane Blutdruckschwankungen. Sber Akad Wiss Wien, 74, 281-307.
31. MØLGAARD H., MICKLEY H., PLESS P., BJERREGAARD P. & MOLLER M. (1993) Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol, 71, 1357-1359.
32. MONTANO N., RUSCONE T. G., PORTA A., LOMBARDI F., PAGANI M. & MALLIANI A. (1994) Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation, 90, 1826-1831.
33. MULDER L. J. M., VAN DELLEN H. J., VAN DER MEULEN P. & OPHEIKENS B. (1988) A spectral analysis program for cardiovascular time series. In: Computers in Psychology: Methods, Instrumentation and Psychodiagnostics (eds Maarse F. J., Mulder L. J. M., Sjouw W. & Akkerman A.), pp. 30-38. Swets & Zeitlinger, Lisse.
34. MULTICENTRE INTERNATIONAL STUDY SUPPLEMENTARY REPORT. (1977) Reduction in mortality after myocardial infarction with long-term beta-adrenoreceptor blockade. Br Med J, 2, 419-421.
35. NIEMELA M. J., AIRAKSINEN K. E. & HUIKURI H. V. (1994) Effect of beta-blockade on heart rate variability in patients with coronary heart disease. J Am Coll Cardiol, 23, 1370-1377.
36. O'LEARY D. S. & WOODBURY D. J. (1996) Role of cardiac output in mediating arterial blood pressure oscillations. Am J Physiol, 271, R641-R646.
37. ODEMUYIWA O., MALIK M., FARRELL T., BASHIR Y., POLONIECKI J. & CAMM J. (1991) Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol, 69, 434-439.
38. PAGANI M., LOMBARDI F., GUZZETTI S., RIMOLDI O., FURLAN R., PIZZINELLI P., SANDRONE G., MALFATTO G., DELL'ORTO S., PICCALUGA E., TURIEL M., BASELLI G., CFRUTTI S. & MALLIANI A. (1986) Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res, 59, 178-193.
39. PEN̄AZ J. (1978) Mayer waves: history and methodology. Automedica, 2, 135-141.
40. PICKERING T. G., GRIBBIN B., STRANGE-PETERSEN E., CUNNINGHAM D. J. C. & SLEIGHT P. (1972) Effects of autonomic blockade on the baroreflex in man at rest and during exercise. Circ Res, 30, 177-185,.
41. PITZALIS M. V., MASTROPASQUA F., PASSANTINO A., MASSARI F., LIGURGO L., FORLEO C., BALDUCCI C., LOMBARDI F. & RIZZON P. (1998) Comparison between noninvasive indices of baroreceptor sensitivity and the phenylephrine method in post-myocardial infarction patients. Circulation, 97, 1362-1367.
42. REYNOLDS J. L. & WHITLOCK R. M. L. (1972) Effects of beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset. Br Heart J, 34, 252-259.
43. RIMOLDI O., PIERINI S., FERRARI A., CERUTTI S., PAGANI M. & MALLIANI A. (1990) Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs. Am J Physiol, 27, H967-H976.
44. ROBBE H. W. J., MULDER L. J. M., RÜDDEL H., LANGEWITZ W. A., VELDMAN J. B. P. & MULDER G. (1987) Assessment of baroreceptor reflex sensitivity by means of spectral analysis. Hypertension, 10, 538-543.
45. ROMPELMAN O., SNIJDERS J. B. & VAN SPRONSEN C. J. (1982) The measurement of heart rate variability spectra with the help of a personal computer. IEEE Trans Biomed Eng, 29, 503-510.
46. SANDRONE G., MORTARA A., TORZILLO D., LA ROVERE M. T., MALLIANI A. & LOMBARDI F. (1994) Effects of beta blockers (atenolol and metoprolol) on heart rate variability after acute myocardial infarction. Am J Cardiol, 94, 340-345.
47. SCHACHINGER H., LANGEWITZ W., RU̇DDEL H., REINO S. T., MULDER L. J. M., VAN ROON A., VELDMAN J. B. P., SCHMIEDER R. & SCHULTE W. (1996) Spectral measures of short-term blood pressure and heart rate variations: methodological considerations. Homeostasis, 37, 97-105.
48. SCHWARTZ P. J., ZAZA A., PALA M., LOCATI E., BERIA G. & ZANCHETTI A. (1988) BRS and its evolution during the first year after myocardial infarction. J Am Coll Cardiol, 12, 629-636.
49. SCHWARTZ P. J., MOTOLESE M., POLLAVINI G., LOTTO A., RUBERTI U., TRAZZI R., BARTORELLI C., ZANCHETTI A. & THE ITALIAN SUDDEN DEATH PREVENTION GROUP. (1992) Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions. J Cardiovasc Electrophysiol, 3, 2-16.
50. SETTELS J. J. & WESSELING K. H. (1985) FTN. A. PRESS: noninvasive finger arterial pressure waveform registration. In: Psychophysiology of Cardiovascular Control (eds Orlebeke J. F., Mulder G. & Van Doornen L. J. P.), pp. 267-283. Plenum Press, New York.
51. SYSTAT. (1992) Statistics, Version 5 2, pp. 1-724. Systat, Evanston, IL.
52. TAYLOR S. H., SILKE B., EBUTT A., SUTTON G. C., PROUT B. J. & BURLEY D. M. (1982) A long-term prevention study with oxprenolol in coronary heart disease. N Engl J Med, 307, 1293-1301.
53. WATKINS L. L., FAINMAN C., DIMSDALE J. & ZIEGLER M. G. (1995) Assessment of baroreflex control from beat-to-beat blood pressure and heart rate changes: a validation study. Psychophysiology, 32, 411-414.
54. WATKINS L., GROSSMAN P. & SHERWOOD A. (1996) Noninvasive assessment of baroreflex control in borderline hypertension. Comparison with the phenylephrine method. Hypertension, 28, 238-243.
55. WILCOX R. G., ROWLEY J. M., HAMPTON J. R., MITCHELL J. R., ROLAND J. M. & BANKS D. C. (1980) Randomized placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet, 2, 765-769.
56. WILHELMSSON C., VEDIN J. A., WILHELMSEN L., TIBBLIN G. & WERKÖ L. (1974) Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet, 2, 1157-1160.
57. WOLF M. M., VARIGOS G. A., HUNT D. & SLOMAN J. G. (1978) Sinus arrhythmia in acute myocardial infarction. Med J Aust, 2, 52-53.
58. YUSUF S., PETO R., LEWIS J., COLLINS R. & SLEIGHT P. (1985) Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis, 5, 335-371.